Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q78124689)
Watch
English
ACR 20: clinical or statistical significance?
scientific article published on 01 August 1999
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
title
ACR 20: clinical or statistical significance?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
main subject
statistics
1 reference
based on heuristic
inferred from title
author name string
Pincus T
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
Stein CM
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
publication date
1 August 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
published in
Arthritis and Rheumatism
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
volume
42
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
issue
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
page(s)
1572-1576
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
cites work
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Prognostic markers of activity and damage in rheumatoid arthritis: why clinical trials and inception cohort studies indicate more favourable outcomes than studies of patients with established disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
An additional basic science for clinical medicine: II. The limitations of randomized trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Radiographic and joint count findings of the hand in rheumatoid arthritis. Related and unrelated findings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Work disability in rheumatoid arthritis: effects of disease, social, and work factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo controlled NSAID trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Auranofin or D-penicillamine in the treatment of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. An open-label extension study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Combination therapy with biologic agents in rheumatoid arthritis: perils and promise
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Large-scale randomized evidence: large, simple trials and overviews of trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Early rheumatoid arthritis: time to aim for remission?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Rheumatoid arthritis: treat now, not later!
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1572%3A%3AAID-ANR2%3E3.0.CO%3B2-G
retrieved
21 January 2018
Identifiers
DOI
10.1002/1529-0131(199908)42:8<1572::AID-ANR2>3.0.CO;2-G
0 references
PubMed publication ID
10446853
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10446853
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10446853%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
